Priti Patel is of Neoleukin Therapeutics, Inc.. Currently has a direct ownership of 37,313 shares of NLTX, which is worth approximately $0. The most recent transaction as insider was on Apr 03, 2023, when has been sold 3,769 shares (Common Stock) at a price of $0.69 per share, resulting in proceeds of $2,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 37.3K
0% 3M change
0% 12M change
Total Value Held $0

Priti Patel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 03 2023
SELL
Open market or private sale
$2,600 $0.69 p/Share
3,769 Reduced 9.17%
37,313 Common Stock
Mar 31 2023
BUY
Exercise of conversion of derivative security
-
10,000 Added 19.58%
41,082 Common Stock
Feb 02 2023
SELL
Open market or private sale
$8,628 $0.6 p/Share
14,380 Reduced 31.63%
31,082 Common Stock
Feb 01 2023
BUY
Exercise of conversion of derivative security
-
35,000 Added 43.5%
45,462 Common Stock
May 02 2022
SELL
Open market or private sale
$6,756 $1.22 p/Share
5,538 Reduced 46.15%
6,462 Common Stock
Apr 30 2022
BUY
Exercise of conversion of derivative security
-
10,000 Added 45.45%
12,000 Common Stock
PP

Priti Patel

Seattle, WA

Track Institutional and Insider Activities on NLTX

Follow Neoleukin Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NLTX shares.

Notify only if

Insider Trading

Get notified when an Neoleukin Therapeutics, Inc. insider buys or sells NLTX shares.

Notify only if

News

Receive news related to Neoleukin Therapeutics, Inc.

Track Activities on NLTX